Business
Teva Pharmaceutical Industries Ltd. will try to win fast European Union approval for its takeover of Allergan’s generics unit by making concessions to regulators,...
Hi, what are you looking for?
Teva Pharmaceutical Industries Ltd. will try to win fast European Union approval for its takeover of Allergan’s generics unit by making concessions to regulators,...
In a letter to the Federal Trade Commission (FTC), The American Antitrust Institute (AAI), a non-profit organization, outlined the competitive concerns raised by the proposed merger...
The exercising of the underwriters' options brings the total raised by Teva Pharmaceuticals in its current offering to $7.24 billion.
Teva Pharmaceutical Industries Ltd has announced today two offerings totaling approximately $6.75 billion of ordinary and preferred shares to fund its takeover of Allergan Plc’s...
Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that the the Japanese Ministry of Health, Labour and Welfare has approved once-daily...
Gecko has developed a cloud-based solution to simplify chronic respiratory disease management through remote monitoring.
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.
Teva CFO Eyal Desheh: We appreciate the strong support we received which stems from the compelling economics of this transaction
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.